Dupilumab yields rapid reductions in nasal polyp burden and improvements in smell function; these benefits persist with extended dosing intervals.
You may be reading this because you or someone you care about has nasal cavity or sinus cancer. Learning more can help you get ready to talk with your healthcare provider and understand the next steps ...
Tezspire (tezepelumab-ekko) is a prescription medicine used to treat inflammatory conditions of the airways, such as severe asthma. The FDA has now approved it as an add-on treatment for adults and ...
Oct 17 (Reuters) - The U.S. Food and Drug Administration has approved Amgen (AMGN.O), opens new tab and AstraZeneca's (AZN.L), opens new tab drug for a type of chronic inflammatory sinus disease, the ...
The FDA approved Amgen's and AstraZeneca's drug to treat chronic rhinosinusitis with nasal polyps, an inflammatory condition of the sinuses and nasal passages. The companies said the approval was ...
Please provide your email address to receive an email when new articles are posted on . Nasal polyp and congestion scores dropped more with stapokibart vs. placebo. Overall nasal symptoms, sense of ...
Addition of the monoclonal antibody stapokibart significantly improved nasal polyps and nasal congestion in adults with uncontrolled chronic rhinosinusitis with nasal polyps, based on new data from ...
the Radiology Department Association of Hospitals of Shanghai, the Molecular Group of Chinese Society of Radiology, the Medical Imaging Committee of Shanghai Association of Chinese Integrative ...
“Not being able to breathe normally makes your whole day feel like a struggle,” Chef Julia Sullivan tells PEOPLE Diana King Julia Sullivan was strolling through the garden of her Nashville home in ...
Laura Schober is a writer and editor specializing in health, food, wellness, beauty, and lifestyle content. Laura is also a seasoned communications professional who has previously worked in the ...
A new CT-scan based risk score facilitates the identification of patients at risk of revision endoscopic sinus surgery due to chronic rhinosinusitis. A new CT-scan based risk score facilitates the ...
A new CT-scan based risk score facilitates the identification of patients at risk of revision endoscopic sinus surgery due to chronic rhinosinusitis. This allows for early prediction of disease ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results